GlassScriptPhysician profile
Kohtaro Ooka
NPI 1003233966
$4,202.36
in general payments reported to CMS, 2019-2025
15 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $235 · 2021: $845 · 2022: $590 · 2023: $216 · 2024: $440 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,761.20 | 2020-2025 | Exalt Model D, Spyglass Discover, Axios |
| Olympus Corporation of The Americas | $754.59 | 2019 | |
| Abbvie INC. | $444.08 | 2020-2022 | |
| Olympus America INC. | $317.75 | 2021-2025 | Single Use Repositionable Clip, Endoclot Phs |
| Micro-Tech Endoscopy USA, INC. | $316.31 | 2025 | Lesionhunter, Eyemax |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.81 | 2020-2024 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $109.57 | 2021-2024 | Entyvio, Eohilia |
| Conmed Corporation | $63.66 | 2020-2025 | Conmed Biliary |
| Creo Medical INC. | $55.44 | 2024 | Speedboat Ultraslim (Sb1l) |
| Lilly USA, LLC | $38.74 | 2025 | Omvoh |
| Fujifilm Healthcare Americas Corporation | $28.92 | 2025 | |
| Braintree Laboratories, INC. | $20.42 | 2021 | |
| Celgene Corporation | $15.26 | 2023 | Zeposia |
| Redhill Biopharma INC. | $14.86 | 2020 | |
| Ambu INC. | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kohtaro Ooka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.